Literature DB >> 17409217

Metallo-beta-lactamase or extended-spectrum beta-lactamase: a wolf in sheep's clothing.

Björn A Espedido1, Lee C Thomas, Jonathan R Iredell.   

Abstract

Diagnostic algorithms in commonly used automated bacterial identification systems fail to reliably identify a metallo-beta-lactamase in the Enterobacteriaceae. Misidentification as an extended-spectrum beta-lactamase may result in inappropriate dismissal of drugs such as aztreonam in favor of carbapenems, which may in turn select for a highly carabapenem resistant phenotype.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17409217      PMCID： PMC1933081          DOI： 10.1128/JCM.02538-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Ability of the VITEK 2 advanced expert system To identify beta-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  C C Sanders; M Peyret; E S Moland; C Shubert; K S Thomson; J M Boeufgras; W E Sanders
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Efficacy of beta-lactams for treating experimentally induced pneumonia due to a carbapenem-hydrolyzing metallo-beta-lactamase-producing strain of Pseudomonas aeruginosa.

Authors:  Samuel Bellais; Olivier Mimoz; Sophie Léotard; Anne Jacolot; Olivier Petitjean; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

3.  Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp.

Authors:  Maurine A Leverstein-van Hall; Ad C Fluit; Armand Paauw; Adrienne T A Box; Sylvain Brisse; Jan Verhoef
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

4.  Carbapenem-hydrolysing metallo-beta-lactamases from Klebsiella pneumoniae and Escherichia coli isolated in Australia.

Authors:  L Poirel; J N Pham; L Cabanne; B J Gatus; S M Bell; P Nordmann
Journal:  Pathology       Date:  2004-08       Impact factor: 5.306

5.  Wide dissemination of a carbapenemase plasmid among gram-negative bacteria: implications of the variable phenotype.

Authors:  Björn Espedido; Jonathan Iredell; Lee Thomas; Anna Zelynski
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

6.  Utility of the VITEK 2 Advanced Expert System for identification of extended-spectrum beta-lactamase production in Enterobacter spp.

Authors:  Mitchell J Schwaber; Shiri Navon-Venezia; Inna Chmelnitsky; Azita Leavitt; David Schwartz; Yehuda Carmeli
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

Review 7.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

8.  Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia.

Authors:  Anton Y Peleg; Clare Franklin; Jan M Bell; Denis W Spelman
Journal:  Clin Infect Dis       Date:  2005-10-31       Impact factor: 9.079

Review 9.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

10.  Inhibition of IMP-1 metallo-beta-lactamase and sensitization of IMP-1-producing bacteria by thioester derivatives.

Authors:  G G Hammond; J L Huber; M L Greenlee; J B Laub; K Young; L L Silver; J M Balkovec; K D Pryor; J K Wu; B Leiting; D L Pompliano; J H Toney
Journal:  FEMS Microbiol Lett       Date:  1999-10-15       Impact factor: 2.742
View more
  7 in total

1.  Predictability of Phenotype in Relation to Common β-Lactam Resistance Mechanisms in Escherichia coli and Klebsiella pneumoniae.

Authors:  Alex Agyekum; Alicia Fajardo-Lubián; Xiaoman Ai; Andrew N Ginn; Zhiyong Zong; Xuejun Guo; John Turnidge; Sally R Partridge; Jonathan R Iredell
Journal:  J Clin Microbiol       Date:  2016-02-24       Impact factor: 5.948

2.  bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.

Authors:  Björn A Espedido; Sally R Partridge; Jonathan R Iredell
Journal:  Antimicrob Agents Chemother       Date:  2008-05-19       Impact factor: 5.191

Review 3.  Expert systems in clinical microbiology.

Authors:  Trevor Winstanley; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

4.  Efficient direct extended-spectrum β-lactamase detection by multiplex real-time PCR: accurate assignment of phenotype by use of a limited set of genetic markers.

Authors:  Justin Ellem; Sally R Partridge; Jonathan R Iredell
Journal:  J Clin Microbiol       Date:  2011-05-25       Impact factor: 5.948

5.  Detection of IMP metallo-β-lactamase in carbapenem-nonsusceptible Enterobacteriaceae and non-glucose-fermenting Gram-negative rods by immunochromatography assay.

Authors:  Shigeyuki Notake; Mari Matsuda; Kiyoko Tamai; Hideji Yanagisawa; Keiichi Hiramatsu; Ken Kikuchi
Journal:  J Clin Microbiol       Date:  2013-03-27       Impact factor: 5.948

6.  Plasmid interference for curing antibiotic resistance plasmids in vivo.

Authors:  Muhammad Kamruzzaman; Shereen Shoma; Christopher M Thomas; Sally R Partridge; Jonathan R Iredell
Journal:  PLoS One       Date:  2017-02-28       Impact factor: 3.240

7.  Persistence of related bla-IMP-4 metallo-beta-lactamase producing Enterobacteriaceae from clinical and environmental specimens within a burns unit in Australia - a six-year retrospective study.

Authors:  Grace Hy Leung; Timothy J Gray; Elaine Yl Cheong; Peter Haertsch; Thomas Gottlieb
Journal:  Antimicrob Resist Infect Control       Date:  2013-12-18       Impact factor: 4.887
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.